Pomalidomide and Infection reactivation - a phase IV clinical study of FDA data

Summary:

Infection reactivation is reported as a side effect among people who take Pomalidomide (pomalidomide), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Carfilzomib, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Infection reactivation when taking Pomalidomide. It is created by eHealthMe based on reports of 14,524 people who have side effects when taking Pomalidomide from the FDA, and is updated regularly.

What is Pomalidomide?

Pomalidomide has active ingredients of pomalidomide. eHealthMe is studying from 14,524 Pomalidomide users. Check the latest studies of Pomalidomide.

What is Infection reactivation?

Infection reactivation is found to be associated with 77 drugs and 158 conditions by eHealthMe. Check the latest studies of Infection reactivation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14,524 people reported to have side effects when taking Pomalidomide.
Among them, 15 people (0.1%) have Infection reactivation.

Could Pomalidomide cause Infection reactivation?

Among these 15 people:

How long have people been on Pomalidomide when they have Infection reactivation? *

What is the gender of people who have Infection reactivation when taking Pomalidomide? *

female: 25 %
male: 75 %

What is the age of people who have Infection reactivation when taking Pomalidomide? *

What are other drugs people take besides Pomalidomide? *

What are other side effects people have besides Infection reactivation? *

Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 14 people, 93.33%
Jc Virus Infection: 13 people, 86.67%
Respirovirus Test Positive: 7 people, 46.67%
Papilloma Viral Infection: 7 people, 46.67%
Metastasis (spreadable cancer to other organ from origin): 7 people, 46.67%
Hypoacusis (loss of hearing): 7 people, 46.67%
Blindness Cortical: 7 people, 46.67%
Anogenital Warts: 7 people, 46.67%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 40.00%
Blindness: 6 people, 40.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 100.00%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 5 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pomalidomide and have Infection reactivation?

- Check whether Infection reactivation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pomalidomide:

Pomalidomide (14,524 reports)

Browse all side effects of Pomalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infection reactivation:

Infection reactivation (77 drugs)

Browse all the conditions that are associated with Infection reactivation:

Infection reactivation (158 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pomalidomide (the active ingredients of Pomalidomide) and Pomalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.